We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Events

26 Oct 2026 - 29 Oct 2026
16 Nov 2026 - 19 Nov 2026

Heat-Activated Skin Patch Targets Melanoma Lesions

By HospiMedica International staff writers
Posted on 06 Apr 2026

Melanoma, a lethal skin cancer, is usually managed with surgical excision. More...

Surgery can be invasive and may not be suitable for all lesions, driving interest in noninvasive therapies. Researchers have now developed a flexible, heat-activated skin patch intended to kill melanoma cells while sparing surrounding tissue. The approach aims to target tumor cells beneath the patch and limit spread.

The stretchable, bandage-like device incorporates laser-induced graphene, a laser-etched porous carbon scaffold, loaded with copper(II) oxide and embedded in a silicone polymer. When positioned over a lesion, the patch conforms to skin, remains breathable, and is chemically inert until activation. The work was published in ACS Nano on March 5, 2026.

Activation is achieved by gently warming the patch with a low-power laser to 108 degrees Fahrenheit (42 degrees Celsius). Under these conditions, the material releases copper ions that interact with cancer cell DNA and induce oxidative stress, leading to cell death. The same pathway is expected to trigger an immune response that inhibits tumor cell migration and potential metastasis.

In laboratory studies, investigators placed the patch over cultured melanoma cells and applied heat to initiate ion release. The activated patch killed most melanoma cells directly beneath it and slowed cellular movement. Surrounding conditions were maintained without evidence of collateral damage in the culture model.

A preliminary 10-day study in mice evaluated in vivo performance. Patches applied to melanoma lesions were activated for one hour on days 1 and 5. The treatment reduced melanoma lesions by 97%, and tissue analyses showed no cancer cell migration beyond tumor borders and no copper accumulation in organs or blood.

The researchers report that the device is reusable and straightforward to administer. Based on these early findings, the technology could someday be adapted for targeted, safe, and efficient noninvasive melanoma treatment in humans.


Gold Member
Blood Gas Analyzer
i-Check200
Hand-held Hemoglobin Analyzer
DiaSpect Tm
Immobilization System
Cranial 4Pi Immobilization
Fetal Monitor
BT-380
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Half-matched bone marrow transplant expands access to curative treatment for children and young adults with severe aplastic anemia. (Photo courtes of Margarita Dionysiou using Bio Render)

Half-Matched Family Donors Could Expand Transplant Access for Severe Aplastic Anemia

Severe aplastic anemia is a rare, life-threatening disorder in which the bone marrow fails to produce enough healthy blood cells, leaving children and young adults vulnerable to anemia, infection, and bleeding.... Read more

Patient Care

view channel
Image: Researchers evaluated the Omni 128 cm long-axial field-of-view PET/CT system, which captures more of the body and radiotracer signal at once, potentially enabling shorter scans. (Photo courtesy of GE HealthCare)

Total-Body PET/CT Scanner Enables One-Minute Diagnostic-Quality Cancer Imaging

Positron emission tomography/computed tomography (PET/CT) combines radiotracer-based functional imaging with anatomical detail to diagnose, stage, and monitor cancer. Conventional scanners image the body... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: Steris is expanding its healthcare consumables portfolio through an agreement to acquire Xodus Medical, a surgical products business focused on patient and operating room staff safety.

Steris to Expand Surgical Safety Portfolio With $2.1 Billion Xodus Medical Deal

Steris has signed a definitive agreement to acquire Xodus Medical, a specialty surgical products business based in Pennsylvania, for $2.1 billion at closing. The acquisition will expand Steris’s healthcare... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.